Stay updated on TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page.

Latest updates to the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page
- Check5 days agoChange DetectedA government funding lapse notice has been added at the top of the page, informing users that information may not be up to date and directing them to cc.nih.gov and opm.gov for status updates.SummaryDifference0.4%

- Check12 days agoChange DetectedAdditions include a 'Show glossary' option, a 'Last Update Submitted that Met QC Criteria' entry, 'No FEAR Act Data', and a 'Revision: v3.4.0' label. Deletions remove 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and the older 'Revision: v3.3.4' label.SummaryDifference0.2%

- Check19 days agoChange DetectedThe page's revision label was updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedLocations section updated to include New York as a study site (New York, United States; Weill Cornell Medicine - New York Presbyterian Hospital). The old 'New York Locations' heading was removed and the page revision updated to v3.3.3.SummaryDifference0.2%

- Check69 days agoChange DetectedRevision tag updated from v3.3.1 to v3.3.2 on the page. This update does not alter study details, eligibility criteria, or trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check76 days agoChange DetectedFooter revision updated to v3.3.1, replacing the prior v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page.